Cancer
JACKSONVILLE, Fla. — Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1[...]
Latest stories
Cardiovascular
November 7, 2024
Research
November 7, 2024
Individualized Medicine
November 6, 2024
Individualized Medicine
November 5, 2024
Health & Wellness
October 31, 2024
Cardiovascular
October 30, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community